Wall Street brokerages forecast that Omega Healthcare Investors, Inc. (NYSE:OHI) will announce sales of $217.83 million for the current fiscal quarter, according to Zacks. Three analysts have issued estimates for Omega Healthcare Investors’ earnings. The highest sales estimate is $237.38 million and the lowest is $180.56 million. Omega Healthcare Investors reported sales of $224.64 million during the same quarter last year, which would suggest a negative year-over-year growth rate of 3%. The company is scheduled to report its next quarterly earnings results on Monday, October 30th.

On average, analysts expect that Omega Healthcare Investors will report full-year sales of $217.83 million for the current financial year, with estimates ranging from $799.85 million to $947.15 million. For the next year, analysts anticipate that the firm will post sales of $938.20 million per share, with estimates ranging from $810.64 million to $1.01 billion. Zacks’ sales calculations are an average based on a survey of research firms that follow Omega Healthcare Investors.

Omega Healthcare Investors (NYSE:OHI) last posted its quarterly earnings data on Wednesday, July 26th. The real estate investment trust reported $0.33 EPS for the quarter, missing analysts’ consensus estimates of $0.49 by $0.16. Omega Healthcare Investors had a net margin of 40.20% and a return on equity of 8.88%. The firm had revenue of $194 million for the quarter, compared to analysts’ expectations of $194.59 million. During the same period in the prior year, the company posted $0.87 earnings per share. Omega Healthcare Investors’s quarterly revenue was up 4.0% compared to the same quarter last year.

Several equities analysts have recently issued reports on OHI shares. Vetr lowered Omega Healthcare Investors from a “hold” rating to a “sell” rating and set a $32.50 target price for the company. in a research report on Monday, April 17th. Zacks Investment Research upgraded Omega Healthcare Investors from a “hold” rating to a “buy” rating and set a $39.00 target price for the company in a research report on Wednesday, April 19th. Jefferies Group LLC restated a “hold” rating and set a $33.00 target price on shares of Omega Healthcare Investors in a research report on Friday, May 12th. Finally, BidaskClub upgraded Omega Healthcare Investors from a “hold” rating to a “buy” rating in a research report on Thursday, June 22nd. Two investment analysts have rated the stock with a sell rating and five have assigned a hold rating to the stock. Omega Healthcare Investors currently has a consensus rating of “Hold” and a consensus price target of $34.38.

In other news, COO Daniel J. Booth sold 20,000 shares of the business’s stock in a transaction dated Monday, June 26th. The stock was sold at an average price of $34.65, for a total transaction of $693,000.00. Following the completion of the transaction, the chief operating officer now directly owns 90,335 shares in the company, valued at approximately $3,130,107.75. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Craig R. Callen bought 15,000 shares of the firm’s stock in a transaction dated Friday, June 2nd. The shares were bought at an average price of $31.40 per share, with a total value of $471,000.00. Following the completion of the transaction, the director now directly owns 18,000 shares in the company, valued at approximately $565,200. The disclosure for this purchase can be found here. 4.54% of the stock is currently owned by insiders.

Several institutional investors have recently modified their holdings of OHI. State Street Corp raised its position in shares of Omega Healthcare Investors by 4.3% in the second quarter. State Street Corp now owns 6,278,985 shares of the real estate investment trust’s stock valued at $207,335,000 after buying an additional 258,035 shares in the last quarter. Cornerstone Capital Management Holdings LLC. raised its position in shares of Omega Healthcare Investors by 189.7% in the second quarter. Cornerstone Capital Management Holdings LLC. now owns 290,211 shares of the real estate investment trust’s stock valued at $9,582,000 after buying an additional 190,049 shares in the last quarter. Janus Henderson Group PLC raised its position in shares of Omega Healthcare Investors by 228.3% in the second quarter. Janus Henderson Group PLC now owns 61,298 shares of the real estate investment trust’s stock valued at $2,024,000 after buying an additional 42,629 shares in the last quarter. Shelton Capital Management raised its position in shares of Omega Healthcare Investors by 24.1% in the second quarter. Shelton Capital Management now owns 15,760 shares of the real estate investment trust’s stock valued at $520,000 after buying an additional 3,058 shares in the last quarter. Finally, Macquarie Group Ltd. raised its position in shares of Omega Healthcare Investors by 16.0% in the second quarter. Macquarie Group Ltd. now owns 65,255 shares of the real estate investment trust’s stock valued at $2,155,000 after buying an additional 9,000 shares in the last quarter. Institutional investors and hedge funds own 74.57% of the company’s stock.

Shares of Omega Healthcare Investors (NYSE OHI) opened at 30.70 on Tuesday. The stock has a market capitalization of $6.06 billion, a price-to-earnings ratio of 16.20 and a beta of 0.50. Omega Healthcare Investors has a 1-year low of $28.11 and a 1-year high of $38.09. The firm’s 50-day moving average is $32.44 and its 200-day moving average is $32.53.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, August 15th. Stockholders of record on Tuesday, August 1st will be given a dividend of $0.64 per share. This is a positive change from Omega Healthcare Investors’s previous quarterly dividend of $0.63. This represents a $2.56 annualized dividend and a dividend yield of 8.34%. The ex-dividend date is Friday, July 28th. Omega Healthcare Investors’s payout ratio is presently 135.45%.

WARNING: “$217.83 Million in Sales Expected for Omega Healthcare Investors, Inc. (OHI) This Quarter” was first reported by American Banking News and is owned by of American Banking News. If you are accessing this article on another website, it was copied illegally and reposted in violation of United States and international copyright and trademark law. The original version of this article can be viewed at https://www.americanbankingnews.com/2017/08/15/217-83-million-in-sales-expected-for-omega-healthcare-investors-inc-ohi-this-quarter.html.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc is a self-administered real estate investment trust (REIT). The Company maintains a portfolio of long-term healthcare facilities and mortgages on healthcare facilities located in the United States and the United Kingdom. It operates through the segment, which consists of investments in healthcare-related real estate properties.

Get a free copy of the Zacks research report on Omega Healthcare Investors (OHI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors Inc. and related companies with MarketBeat.com's FREE daily email newsletter.